The Lynchburg community and loved ones celebrated the life and legacy of our former evening news anchor, Mark Spain.

On Saturday the family of Mark Spain, his work family here at WSET, and those whose lives he touched will celebrate his life.

Over the past three weeks, the entire Lynchburg region offered well wishes and love for Mark Spain ... stage 4 pancreatic cancer. Only weeks after the diagnosis, WSET reported Spain died on ...

The year 2024 marked a transformative period for scientific research, driven by the aftermath of the <a target=_blank href= ...

Sunny with a high of 58 °F (14.4 °C). Winds variable. Night - Clear. Winds variable at 3 to 8 mph (4.8 to 12.9 kph). The overnight low will be 44 °F (6.7 °C). Mostly cloudy today with a high ...

Night - Cloudy with a 40% chance of precipitation. Winds variable. The overnight low will be 38 °F (3.3 °C). Cloudy with a high of 53 °F (11.7 °C) and a 60% chance of precipitation. Winds ...

FibroGen has pulled the plug on its lead drug pamrevlumab after two failed trials in pancreatic cancer and immediately announced plans to shed three-quarters of its workforce. The San Francisco ...

Chemoradiation is considered a reasonable treatment option for patients with locally advanced, unresectable pancreatic cancer. The chemotherapy agents 5-fluorouracil, gemcitabine, capecitabine and ...

Jan. 2, 2025 — An enzyme called MICAL2 promotes tumor growth and metastasis in the most common form of pancreatic cancer, according to a new ... Advanced Imaging Uncovers Hidden Metastases in ...

Th-302 is an investigational hypoxia-targeted drug for patients with advanced pancreatic cancer. The Phase 2 findings indicated that patients treated with Gemzar (Eli Lilly’s chemotherapy drug ...

The addition of erlotinib to gemcitabine is the only combination that has demonstrated an improvement in progression-free survival in patients with pancreatic cancer. The role for other anti-VEGF ...